Alnylam to partner with Scangos-led biotech on infectious disease drugs
October 18, 2017 at 11:15 AM EDT
The collaboration deal was the second announced on Wednesday by Vir Biotechnology involving a Cambridge biotech.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|